Want to see HK:0718 full AI Analyst Report?
0718 Stock Chart & Stats
HK$0.06
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$0.06
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.03 - HK$0.07
Previous CloseN/A
Volume25.00K
Average Volume (3M)1.14M
Market Cap
HK$152.25M
Enterprise ValueHK$1.58K
Total Cash (Recent Filing)HK$88.96M
Total Debt (Recent Filing)HK$1.50B
Price to Earnings (P/E)―
Beta4.80
Next Earnings
Aug 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding5,250,020,000
10 Day Avg. Volume220,500
30 Day Avg. Volume1,144,937
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.08
Price to Sales (P/S)1.34
P/FCF Ratio8.67
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Positive Cash FlowPositive operating and free cash flow provides a recurring funding source despite reported losses. If maintained, it could support core operations and reduce reliance on external financing, although current cash generation remains limited.
Improved Gross MarginThe improvement in gross margin suggests some progress in revenue economics and service delivery efficiency. Sustaining this gain could improve operating leverage over time, provided revenue quality strengthens and overhead is controlled.
Modest Revenue StabilizationA return to modest revenue growth after the prior contraction indicates potential stabilization in the operating base. Continued growth would help absorb fixed costs and provide a foundation for rebuilding profitability, though momentum remains limited.
Bears Say
Negative Equity And Solvency RiskNegative equity materially weakens financial flexibility and raises solvency risk. High debt can constrain investment, increase refinancing dependence, and leave limited protection for creditors if operating performance deteriorates further.
Persistent UnprofitabilityRecurring losses indicate that the business has not yet demonstrated a sustainable earnings model. Continued negative margins can consume capital, weaken lender confidence, and limit the company’s ability to self-fund growth.
Volatile And Insufficient Cash GenerationCash generation lacks a stable multi-year pattern and is too small relative to the company’s losses and debt burden. This limits deleveraging capacity and increases dependence on asset sales, financing, or operational recovery.
Tai United Holdings News
0718 FAQ
What was Tai United Holdings Limited’s price range in the past 12 months?
Tai United Holdings Limited lowest stock price was HK$0.03 and its highest was HK$0.07 in the past 12 months.
What is Tai United Holdings Limited’s market cap?
Tai United Holdings Limited’s market cap is HK$152.25M.
When is Tai United Holdings Limited’s upcoming earnings report date?
Tai United Holdings Limited’s upcoming earnings report date is Aug 31, 2026 which is in 3 days.
How were Tai United Holdings Limited’s earnings last quarter?
Tai United Holdings Limited released its earnings results on Mar 31, 2026. The company reported -HK$0.033 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Tai United Holdings Limited overvalued?
According to Wall Street analysts Tai United Holdings Limited’s price is currently Overvalued.
Does Tai United Holdings Limited pay dividends?
Tai United Holdings Limited pays a Notavailable dividend of HK$0.2 which represents an annual dividend yield of N/A. See more information on Tai United Holdings Limited dividends here
What is Tai United Holdings Limited’s EPS estimate?
Tai United Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tai United Holdings Limited have?
Tai United Holdings Limited has 5,250,020,000 shares outstanding.
What happened to Tai United Holdings Limited’s price movement after its last earnings report?
Tai United Holdings Limited reported an EPS of -HK$0.033 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Tai United Holdings Limited?
Currently, no hedge funds are holding shares in HK:0718
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Tai United Holdings Limited
Tai United Holdings Limited operates as an investment holding company, primarily directing its capital into real estate ventures across the People's Republic of China, Singapore, the United States, the United Kingdom, and the Republic of Mongolia. The firm's operations are structured into five principal divisions: Property Investment, Medical Equipment Trading, Flooring Materials Trading, Mining and Exploitation of Natural Resources, and Financial Services and Asset Management. The Property Investment segment is responsible for acquiring, managing, and leasing various properties, in addition to developing retail complexes. The Medical Equipment Trading division engages in the commerce of healthcare apparatus. Flooring Materials Trading specializes in the distribution and sale of floor coverings. The Mining and Exploitation of Natural Resources segment focuses on the extraction and production of tungsten resources. Lastly, the Financial Services and Asset Management segment handles trading in equity securities and derivatives, as well as overseeing assets that originate from the acquisition of distressed debts. Established in 1995, the company was formerly recognized as Bestway International Holdings Limited before officially adopting the name Tai United Holdings Limited in August 2016. Its corporate headquarters are located in North Point, Hong Kong, and it functions as a subsidiary of Songbird SG PTE. Ltd.
Technical Analysis
China Health Group
―
Shanghai Pharmaceuticals Holding Co
―
Sinopharm Group Co
―
IVD Medical Holding Limited
―
Medlive Technology Co., Ltd.
―